Loading insider details...
Latest Form 4 (Oct 28, 2026): Grant/Award of 57,500 CRSP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 28, 2026 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 57,500 | n/a |
| Oct 20, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 100,000 | n/a |
| Oct 15, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 8,333 | n/a |
| Jun 29, 2026 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 40,000 | n/a |
| Jun 24, 2026 | Centessa Pharmaceuticals plc (CNTA) | Disposition to Issuer | 208,474 | n/a |
| Jun 3, 2026 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 9,136 | n/a |
| Mar 24, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 19,687 | n/a |
| Mar 17, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 20,625 | n/a |
| Mar 12, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 19,250 | n/a |
| Feb 20, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 13,250 | n/a |